Analysis of 24-hour Death Risk Factors in Circulatory Failure Patients Treated with Venoarterial Extracorporeal Membrane Oxygenation

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Jianwei Wang
Format: Artículo científico
Language:en
Published: Sociedade Brasileira de Cirurgia Cardiovascular 2023
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876488958691508224
author Jianwei Wang
author_facet Jianwei Wang
contents Analysis of 24-hour Death Risk Factors in Circulatory Failure Patients Treated with Venoarterial Extracorporeal Membrane Oxygenation Jianwei Wang Shengshu Wang Yang Song MingJun Huang Wenzhe Cao Shaohua Liu Shimin Chen Xuehang Li Miao Liu Yao He Medicina Prognosis Risk Factors Hospital Mortality Cardiopulmonary Failure Extracorporeal Membrane Oxygenation Objective To explore the factors affecting short-term prognosis of circulatory failure patients undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO) treatment.Methods A total of 136 patients undergoing VA-ECMO were enrolled in this study and subsequently divided into the death group (n=35) and the survival group (n=101) based on whether death occurred during hospitalisation. Extracorporeal membrane oxygenation (ECMO) running time, length of intensive care unit stay, length of hospital stay, costs, and ECMO complications were then compared between the two groups.Results The average age of all patients undergoing ECMO was 47.64±16.78 years (53.2±16.20 years in the death group and 45.713±16.62 years in the survival group) (P=0.022). Patients in the survival group exhibited a clear downward trend in lactic acid value following ECMO treatment compared to those in the death group. Total hospitalisation stay was longer in the survival group (35 days) than in the death group (15.5 days) (P<0.001). In the analysis of ECMO complications, the incidence of neurological complications, renal failure, limb complications, and infection were higher in the death group than in the survival group (P<0.05 for all). Specifically, as a risk factor for patient survival and discharge, the occurrence of infection will lead to increased hospitalisation stays and costs (P<0.05 for both).Conclusion Complications such as kidney failure and infection are associated with in-hospital death, and ECMO-related complications should be actively prevented to improve the survival rate of VA-ECMO treatment. 2023 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398975781007 https://www.redalyc.org/journal/3989/398975781007/ https://www.redalyc.org/journal/3989/398975781007/html/ https://www.redalyc.org/journal/3989/398975781007/398975781007.epub https://www.redalyc.org/journal/3989/398975781007/movil 10.21470/1678-9741-2022-0398 en http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.6 Vol.38
format Artículo científico
id redalyc_398975781007
institution Redalyc
language en
publishDate 2023
publisher Sociedade Brasileira de Cirurgia Cardiovascular
spellingShingle Analysis of 24-hour Death Risk Factors in Circulatory Failure Patients Treated with Venoarterial Extracorporeal Membrane Oxygenation
Jianwei Wang
Medicina
Prognosis
Risk Factors
Hospital Mortality
Cardiopulmonary Failure
Extracorporeal Membrane Oxygenation
Analysis of 24-hour Death Risk Factors in Circulatory Failure Patients Treated with Venoarterial Extracorporeal Membrane Oxygenation Jianwei Wang Shengshu Wang Yang Song MingJun Huang Wenzhe Cao Shaohua Liu Shimin Chen Xuehang Li Miao Liu Yao He Medicina Prognosis Risk Factors Hospital Mortality Cardiopulmonary Failure Extracorporeal Membrane Oxygenation Objective To explore the factors affecting short-term prognosis of circulatory failure patients undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO) treatment.Methods A total of 136 patients undergoing VA-ECMO were enrolled in this study and subsequently divided into the death group (n=35) and the survival group (n=101) based on whether death occurred during hospitalisation. Extracorporeal membrane oxygenation (ECMO) running time, length of intensive care unit stay, length of hospital stay, costs, and ECMO complications were then compared between the two groups.Results The average age of all patients undergoing ECMO was 47.64±16.78 years (53.2±16.20 years in the death group and 45.713±16.62 years in the survival group) (P=0.022). Patients in the survival group exhibited a clear downward trend in lactic acid value following ECMO treatment compared to those in the death group. Total hospitalisation stay was longer in the survival group (35 days) than in the death group (15.5 days) (P<0.001). In the analysis of ECMO complications, the incidence of neurological complications, renal failure, limb complications, and infection were higher in the death group than in the survival group (P<0.05 for all). Specifically, as a risk factor for patient survival and discharge, the occurrence of infection will lead to increased hospitalisation stays and costs (P<0.05 for both).Conclusion Complications such as kidney failure and infection are associated with in-hospital death, and ECMO-related complications should be actively prevented to improve the survival rate of VA-ECMO treatment. 2023 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398975781007 https://www.redalyc.org/journal/3989/398975781007/ https://www.redalyc.org/journal/3989/398975781007/html/ https://www.redalyc.org/journal/3989/398975781007/398975781007.epub https://www.redalyc.org/journal/3989/398975781007/movil 10.21470/1678-9741-2022-0398 en http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.6 Vol.38
title Analysis of 24-hour Death Risk Factors in Circulatory Failure Patients Treated with Venoarterial Extracorporeal Membrane Oxygenation
topic Medicina
Prognosis
Risk Factors
Hospital Mortality
Cardiopulmonary Failure
Extracorporeal Membrane Oxygenation
url https://www.redalyc.org/articulo.oa?id=398975781007
https://www.redalyc.org/journal/3989/398975781007/
https://www.redalyc.org/journal/3989/398975781007/html/
https://www.redalyc.org/journal/3989/398975781007/398975781007.epub
https://www.redalyc.org/journal/3989/398975781007/movil